71287-220Level 3
TECARTUS (brexucabtagene autoleucel)
**Product type:** Cellular Therapy
**Active ingredient:** BREXUCABTAGENE AUTOLEUCEL
**Strength:** 1000000 1/68mL
**Dosage form:** Suspension
**Route:** Intravenous
**Labeler:** Kite Pharma, Inc.
**Marketing category:** BLA (BLA125703)
GET
/api/v1/systems/ndc_fda/nodes/71287-220Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.